COMPANY
PharmatrophiX
PharmatrophiX is a clinical-stage biopharmaceutical company focused on the discovery and development of disease-modifying therapies for neurodegenerative diseases. From company website Source · Oct 12, 2026
Timeline
- Trial start Phase 1/Phase 2: Study of LM11A-31-BHS in Mild-moderate AD Patients source ↗
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT03069014 | Study of LM11A-31-BHS in Mild-moderate AD Patients | Phase 1/Phase 2 | Completed | Feb 15, 2017 | Jun 8, 2020 (actual) |